Clinical trials
Active, not recruiting Kidney Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 5 |
| M.D. Anderson Cancer Center | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Actuate Therapeutics Inc. | 1 |
| Ajjai Alva, MD | 1 |
| Arsenal Biosciences, Inc. | 1 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
| DEKA Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 42 |
| Carcinoma, Renal Cell | 22 |
| Urinary Bladder Neoplasms | 9 |
| Lung Neoplasms | 8 |
| Neoplasms | 8 |
| Breast Neoplasms | 7 |
| Prostatic Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Head and Neck Neoplasms | 5 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.